Nanoparticle platform could improve tumor bioimaging and detection

Researchers from the KTH Royal Institute of Technology (Stockholm, Sweden) report on engineered nanoparticles that may improve the in vivo detection of tumors in both the body and biopsy tissue. When performing visualizations of living tissues, good contrast imaging depends on fluorescent dyes and biomolecules to differentiate between structures. Nanoparticle research has, in recent years, been at the forefront of such imaging techniques. The research team combined optical and X-ray fluorescence contrast agents to create a single enhancer, introducing a new method of in vivo tumor diagnosis using X-ray fluorescence computed tomography. A core combination of nanoparticles is encased in...